Use access key #2 to skip to page content.
$4.44 -0.06 (-1.33%)
7/3/2008 1:00 PM

Dendreon Corp (DNDN)

CAPS Rating:
**

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

View All Commentary (DNDN)

Recs

0

Avatar dinovaselino (< 20) Submitted: 5/15/08 5:32 PM : Underperform Start Price: $5.55 DNDN Score: 8.46

Spec. play on penny stock. Might be good for trading now while


waiting for more concrete news on FDA appoval. Might be a good


Idea to have some CEGE as well.

Report this Post Replies: 0 | Reply

Featured Broker Partners